Nalaganje...

RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma

INTRODUCTION: Oncogenic RET tyrosine kinase gene fusions and activating mutations have recently been identified in lung cancers, prompting initiation of targeted therapy trials in this disease. Although RET point mutation has been identified as a driver of tumorigenesis in medullary thyroid carcinom...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Endocrinol Metab
Main Authors: Grubbs, Elizabeth G., Ng, Patrick Kwok-Shing, Bui, Jacquelin, Busaidy, Naifa L., Chen, Ken, Lee, Jeffrey E., Lu, Xinyan, Lu, Hengyu, Meric-Bernstam, Funda, Mills, Gordon B., Palmer, Gary, Perrier, Nancy D., Scott, Kenneth L., Shaw, Kenna R., Waguespack, Steven G., Williams, Michelle D., Yelensky, Roman, Cote, Gilbert J.
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4333032/
https://ncbi.nlm.nih.gov/pubmed/25546157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4153
Oznake: Označite
Brez oznak, prvi označite!